the story of glp 1 GLP-1 Memoirs have resource to make it easier than ever. Reflections on the discovery GLP-1
Description
Consensus recommendations on utilizing glucagon-like peptide-1 (GLP-1) receptor agonists in the treatment of type 2 diabetes mellitus
The maintenance dose pricing has not yet been announced
Regular aerobic activity (like brisk walking, cycling, swimming) can lower cardiovascular risk by 3040%, which is better than some medications
doi: 10.1523/JNEUROSCI.19-07-02799.1999
Since 2021, GLP-1s have eroded metformin as the preferred first-line therapy for many patients, despite metformins lower cost and oral administration
